Who Owns Telomir Pharmaceuticals Stock?
NASDAQ: TELOHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 4.03%
- Held by insiders
- 42.98%
- Institutional holders
- 35
- Institutions 4.0%
- Insiders 43.0%
- Public and other 53.0%
Who owns Telomir Pharmaceuticals stock?
Institutional investors own about 4.0% of Telomir Pharmaceuticals's shares, spread across 35 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 42.98% of TELO.
The largest institutional holders are Vanguard Capital Management LLC (2.35%), Geode Capital Management, LLC (0.49%) and Blackrock Inc. (0.41%). Together, the top 10 institutions control 4.0% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their TELO positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TELO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 1.61M | 2.35% | +62.1% |
| Geode Capital Management, LLC | 338.88K | 0.49% | +36.0% |
| Blackrock Inc. | 280.47K | 0.41% | -3.0% |
| Vanguard Fiduciary Trust Co | 225.30K | 0.33% | +66.2% |
| Northern Trust Corporation | 61.53K | 0.09% | +47.0% |
| State Street Corporation | 58.60K | 0.09% | 0.0% |
| Bank Of New York Mellon Corporation | 51.45K | 0.07% | 0.0% |
| CAPTRUST Financial Advisors | 51.19K | 0.07% | +100.0% |
| Osaic Holdings Inc. | 41.49K | 0.06% | +15.9% |
| World Investment Advisors | 37.04K | 0.05% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TELO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.12M | 1.63% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 472.62K | 0.69% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 210.40K | 0.31% |
| iShares Trust-iShares Micro-Cap ETF | 36.93K | 0.05% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 36.55K | 0.05% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 30.10K | 0.04% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 19.84K | 0.03% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 14.33K | 0.02% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 2.47K | 0.00% |
Frequently asked questions
Who is the largest shareholder of Telomir Pharmaceuticals?
Vanguard Capital Management LLC is the largest institutional shareholder of TELO, owning 2.35% of shares outstanding (1.61M shares) as of its latest 13F filing.
What percentage of Telomir Pharmaceuticals is owned by institutions?
Institutions own about 4.0% of TELO shares and 7.1% of the public float.
How much of Telomir Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 42.98% of TELO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.